Related to AD, previous studies have shown that RIPK1 is increased in patient brains, specifically in microglial cells surrounding β-amyloid plaques, indicating that it might be involved in regulating disease-associated microglial function (Ofengeim et al., 2017). The gene discussed is RIPK1; the disease is Alzheimer disease.